HylaPharm

Overview
Animal Therapeutics?
Product stageSegments
Seed
?
Oncology therapeutics
?

HylaPharm is a university spinout company that develops targeted cancer therapies and cancer drugs. It offers HylaPlat, a new cancer drug that has already shown efficacy in multiple mouse models, and in several dogs with large, naturally occurring cancers.

HQ location:
2029 Becker Drive Suite 285 Lawrence KS USA
Founded year:
2010
Employees:
1-10
IPO status:
Private
Total funding:
USD 500.0 k
Last Funding:
USD 500.0 k (Seed; Dec 2014)
Last valuation:
-
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.